Terms: = Skin cancer AND FOXO4, P98177, 4303, ENSG00000184481, MLLT7, AFX1
5 results:
1. Molecular modelling of the foxo4-TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells.
Le HH; Cinaroglu SS; Manalo EC; Ors A; Gomes MM; Duan Sahbaz B; Bonic K; Origel Marmolejo CA; Quentel A; Plaut JS; Kawashima TE; Ozdemir ES; Malhotra SV; Ahiska Y; Sezerman U; Bayram Akcapinar G; Saldivar JC; Timucin E; Fischer JM
EBioMedicine; 2021 Nov; 73():103646. PubMed ID: 34689087
[TBL] [Abstract] [Full Text] [Related]
2. A Summation Analysis of Compliance and Complications of Compression Hosiery for Patients with Chronic Venous Disease or Post-thrombotic Syndrome.
Kankam HKN; Lim CS; Fiorentino F; Davies AH; Gohel MS
Eur J Vasc Endovasc Surg; 2018 Mar; 55(3):406-416. PubMed ID: 29329662
[TBL] [Abstract] [Full Text] [Related]
3. Multifaceted functions of the forkhead box transcription factors FoxO1 and FoxO3 in skin.
Tsitsipatis D; Klotz LO; Steinbrenner H
Biochim Biophys Acta Gen Subj; 2017 May; 1861(5 Pt A):1057-1064. PubMed ID: 28249743
[TBL] [Abstract] [Full Text] [Related]
4. Activation of forkhead box O transcription factors by oncogenic BRAF promotes p21cip1-dependent senescence.
de Keizer PL; Packer LM; Szypowska AA; Riedl-Polderman PE; van den Broek NJ; de Bruin A; Dansen TB; Marais R; Brenkman AB; Burgering BM
Cancer Res; 2010 Nov; 70(21):8526-36. PubMed ID: 20959475
[TBL] [Abstract] [Full Text] [Related]
5. Cost comparisons of managing complex facial basal cell carcinoma: Canadian study.
Lear W; Mittmann N; Barnes E; Breen D; Murray C
J Cutan Med Surg; 2008; 12(2):82-7. PubMed ID: 18346405
[TBL] [Abstract] [Full Text] [Related]
